Pluri Inc.

Healthcare · Biotechnology · Israel

Last price 1.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 14.81M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. Its product candidates include PLX-PAD, which is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle...